Object: The aim of this study was to reveal variations in the patterns of expression of the cell surface proteins in regenerating fibers and those in the number of satellite cells to gain an understanding of the pathological processes involved in sarcoglycanopathy. Methods: Wehave reported that there is a reduction of the beta-1 subunit of laminin, heparan sulfate proteoglycan (HSPG), and HCAM(CD44) in Japanese patients with sarcoglycanopathy.
Introduction
Sarcoglycanopathy is a genetically heterogeneous disease including LGMD2C, linked to the gamma-sarcoglycan gene on chromosome 13q (1); LGMD2D, linked to the alphasarcoglycan gene on chromosome 17q (2); LGMD2E, linked to the beta-sarcoglycan gene on chromosome4q (3, 4) ; and LGMD2F, linked to the delta-sarcoglycan gene on chromosome 5q (5) . The physiological role of each sarcoglycan protein and the pathophysiology of sarcoglycanopathy are poorly understood. Wehave reported that there is reduction of the beta-1 subunit of laminin, heparan sulfate proteoglycan (HSPG), and HCAM in*Japanese patients with sarcoglycanopathy (6) (7) (8) . The expression of the CD24molecule, a glycoprotein expressed on the surface of most B lymphocytes and differentiating neuroblasts, was reported to be associated with a subpopulation of regenerative fibers in diseased muscles (9) . Neural cell adhesion molecule (NCAM) was expressed in regenerating fibers, satellite cells, and denervated muscle fibers (10) . Theaim of the study was to reveal variations in the patterns of expression of the cell surface proteins in regenerating fibers and those in the number of satellite cells to gain an understanding of the pathological processes involved in sarcoglycanopathy.
CD24 in Sarcoglycanopathy Materials
and Methods
Pa tien ts
Wehave already reported the details of the 6 patients with sarcoglycanopathy (6, 8, ll, 12) ; and the clinical data for these 6 patients are presented in Biotinylated anti-mouse immunoglobulin GL (IgG) was used as the secondary antibody, and the ABCmethod (13) was used for signal detection (ABCkit; Vector). The sections were counterstained with hematoxylin for 5 seconds. All immunohistochemical procedures were as reported previously (8).
Statistical analysis
The incidences of NCAM-positive and CD24-positive fibers were obtained as a percentage of 500 randomly selected fibers exhibiting positive staining. The percentage of NCAM positive satellite cells per 500 myonuclei in non-necrotic muscle fibers, which were evaluated in the serial section stained with hematoxylin and eosin, was calculated for each cases. The statistical significance of the differences between sarcoglycanopathy and BMDwas analyzed by Mann-Whitney Utest.
Results
Dystrophin and beta-dystroglycan were expressed at nearnormal level on the muscle cell membranein all the patients with sarcoglycanopathy. However, alpha-sarcoglycan, betasarcoglycan, and gamma-sarcoglycan were deficient or markedly reduced on the muscle cell membranein all the patients with sarcoglycanopathy.
The results of immunohistochemical analysis of CD24and NCAMare shown in Fig. 1 and Fig. 2 and HCAM, and suspected the failure of signal transduction of growth factors, or the dysfunction of other heparan sulfatebinding proteins. In our previous study (8) we reported that NCAM was upregulated in a fair numberof muscle fibers in muscular dystrophy including sarcoglycanopathy, however we did not count the NCAM-positive satellite cells separately. The present study was focused on the regeneration of muscle fibers, and disclosed the poor expression of CD24and fewer satellite cells (small regenerating fibers with little sarcoplasm may be included) in sarcoglycanopathy compared to BMD.We consider that the difference is not due to a difference in the number of total regenerating fibers, but due to a difference in the regeneration process of musclefibers, or to other unknown CD24 in Sarcoglycanopathy factors, because the incidences of total NCAM-positive fibers were not statistically different between sarcoglycanopathy and age-matched BMD.Furthermore, it is not likely that the difference is due to the clinical stage of the disease or age of the patient. It has been reported that both NCAM and CD24are expressed in regenerating fibers (9, 10) , and the number of CD24-positive fibers is always lower than that of NCAM-positive fibers (9) , however, the details of the pathological difference between the fibers are largely unknown. It has been reported that very few muscle fibers express polysialylated NCAM and CD24in childhood spinal muscular atrophies (14) . Since the diameter of CD24-positive fibers seem to be smaller than that of NCAM-positive fibers, CD24appears to be expressed in the early stages of the regeneration process. Taken together, the poor expression of CD24and the fewer satellite cells in sarcoglycanopathy suggest that the time schedule of necrosis to regeneration is different between sarcoglycanopathy and BMD.One possible explanation for the difference is that the differentiation of satellite cells in sarcoglycanopathy is similar to that in BMDbut the proliferation or recruitment of satellite cells in sarcoglycanopathy may be less active than that in BMD.
The CD24 is a glycosyl phosphatidylinositol (GPI)-linked glycoprotein expressed on hematopoietic cells, including B cells, T cells and granulocytes, and on non-hematopoietic cells, including neural cells. It has been reported that CD24 may play a role in cell adhesion, or as a signal transducing molecule (15) (16) (17) (18) . A CDNA that directs the expression of CD24on the surfaces of transfected COScells was cloned on the basis of its homologyto a CDNA encoding the murine heat stable antigen ( 19) . Figarella-Branger et al (9) reported that CD24 immunoreactivity was only observed in someunmyelinated nerve fibers in normal adult muscles, and CD24expression was always associated with a subpopulation of regenerative fibers in diseased muscles. The function of CD24in muscle fibers has not been fully determined, but since the molecule is not expressed in developing human muscle fibers (9), CD24 expression may be important in the regeneration process in diseased muscle but not in the normal development of muscle fibers. The present study disclosed that the poor expression of CD24 in musclefibers and the fewer satellite cells are characteristic findings in sarcoglycanopathy, in addition to reduction of the beta-1 subunit of laminin, HSPG, and HCAM. It would be important to determine if the poor expression of CD24 and the fewer satellite cells are commonto all patients with sarcoglycanopathy, in particular, in patients at early stages of the disease. Future experiments are necessary to determine the exact role of CD24in muscle fibers, and to determine if the dysfunction of regeneration is relevant to the pathogenesis of sarcoglyc anopathy.
